197 related articles for article (PubMed ID: 36135958)
1. Systemic sclerosis: one year in review 2022.
Lepri G; Orlandi M; Di Battista M; De Mattia G; Da Rio M; Codullo V; Guiducci S; Della Rossa A
Clin Exp Rheumatol; 2022 Oct; 40(10):1911-1920. PubMed ID: 36135958
[TBL] [Abstract][Full Text] [Related]
2. One year in review 2020: systemic sclerosis.
Orlandi M; Lepri G; Damiani A; Barsotti S; Di Battista M; Codullo V; Della Rossa A; Guiducci S; Allanore Y
Clin Exp Rheumatol; 2020; 38 Suppl 125(3):3-17. PubMed ID: 32662404
[TBL] [Abstract][Full Text] [Related]
3. One year in review 2016: systemic sclerosis.
Barsotti S; Stagnaro C; d'Ascanio A; Della Rossa A
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):3-13. PubMed ID: 27463613
[TBL] [Abstract][Full Text] [Related]
4. One year in review 2021: systemic sclerosis.
Di Battista M; Barsotti S; Orlandi M; Lepri G; Codullo V; Della Rossa A; Guiducci S; Del Galdo F
Clin Exp Rheumatol; 2021; 39 Suppl 131(4):3-12. PubMed ID: 34251323
[TBL] [Abstract][Full Text] [Related]
5. Systemic Sclerosis Pathogenesis and Emerging Therapies, beyond the Fibroblast.
Sierra-Sepúlveda A; Esquinca-González A; Benavides-Suárez SA; Sordo-Lima DE; Caballero-Islas AE; Cabral-Castañeda AR; Rodríguez-Reyna TS
Biomed Res Int; 2019; 2019():4569826. PubMed ID: 30809542
[TBL] [Abstract][Full Text] [Related]
6. Targeting interferons as a strategy for systemic sclerosis treatment.
Ciechomska M; Skalska U
Immunol Lett; 2018 Mar; 195():45-54. PubMed ID: 29106987
[TBL] [Abstract][Full Text] [Related]
7. Systemic sclerosis.
Volkmann ER; Andréasson K; Smith V
Lancet; 2023 Jan; 401(10373):304-318. PubMed ID: 36442487
[TBL] [Abstract][Full Text] [Related]
8. One year in review 2017: systemic sclerosis.
Barsotti S; Bruni C; Orlandi M; Della Rossa A; Marasco E; Codullo V; Guiducci S
Clin Exp Rheumatol; 2017; 35 Suppl 106(4):3-20. PubMed ID: 29035173
[TBL] [Abstract][Full Text] [Related]
9. [Systemic sclerosis--clinical course and treatment possibilities].
Szymańska E; Maj M; Rudnicka L
Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
[TBL] [Abstract][Full Text] [Related]
10. One year in review 2019: systemic sclerosis.
Barsotti S; Orlandi M; Codullo V; Di Battista M; Lepri G; Della Rossa A; Guiducci S
Clin Exp Rheumatol; 2019; 37 Suppl 119(4):3-14. PubMed ID: 31587697
[TBL] [Abstract][Full Text] [Related]
11. [Systemic sclerosis--pathogenesis, clinical manifestations and treatment].
Radić M; Kaliterna DM; Fabijanić D; Radić J
Lijec Vjesn; 2010; 132(5-6):162-8. PubMed ID: 20677623
[TBL] [Abstract][Full Text] [Related]
12. [Recommendations for diagnosis and treatment of systemic sclerosis in China].
Zou HJ; Zhu XX; Dai SM; Wang XB; Zhao DB; Zhao Y
Zhonghua Nei Ke Za Zhi; 2022 Aug; 61(8):874-882. PubMed ID: 35922211
[TBL] [Abstract][Full Text] [Related]
13. The contemporary management of systemic sclerosis.
Eldoma M; Pope J
Expert Rev Clin Immunol; 2018 Jul; 14(7):573-582. PubMed ID: 29874475
[TBL] [Abstract][Full Text] [Related]
14. Type I interferon dysregulation in Systemic Sclerosis.
Skaug B; Assassi S
Cytokine; 2020 Aug; 132():154635. PubMed ID: 30685202
[TBL] [Abstract][Full Text] [Related]
15. Systemic sclerosis: one year in review 2023.
Di Battista M; Lepri G; Codullo V; Da Rio M; Fiorentini E; Della Rossa A; Guiducci S
Clin Exp Rheumatol; 2023 Aug; 41(8):1567-1574. PubMed ID: 37199215
[TBL] [Abstract][Full Text] [Related]
16. Scleromyositis: A distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis.
Giannini M; Ellezam B; Leclair V; Lefebvre F; Troyanov Y; Hudson M; Senécal JL; Geny B; Landon-Cardinal O; Meyer A
Front Immunol; 2022; 13():974078. PubMed ID: 36776390
[TBL] [Abstract][Full Text] [Related]
17. Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis.
Stenström M; Nyhlén HC; Törngren M; Liberg D; Sparre B; Tuvesson H; Eriksson H; Leanderson T
J Dermatol Sci; 2016 Jul; 83(1):52-9. PubMed ID: 27156795
[TBL] [Abstract][Full Text] [Related]
18. Ten years of a systemic sclerosis clinic in a tertiary referral centre - insights and future directions.
Martins P; Dourado E; Fonseca JE; Cordeiro I; Romão VC; Resende C
Acta Reumatol Port; 2021; 46(3):257-265. PubMed ID: 34628459
[TBL] [Abstract][Full Text] [Related]
19. [Systemic sclerosis].
Legendre P; Mouthon L
Rev Prat; 2017 Sep; 67(7):775-783. PubMed ID: 30512777
[TBL] [Abstract][Full Text] [Related]
20. Treating skin and lung fibrosis in systemic sclerosis: a future filled with promise?
Antic M; Distler JH; Distler O
Curr Opin Pharmacol; 2013 Jun; 13(3):455-62. PubMed ID: 23747024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
